|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:252-253
© 2006 The American Association for Thoracic Surgery
Letter to the Editor |
Department of Anesthesiology, University of Würzburg, Würzburg, Germany
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the article by Canyon and Dobson
1
presenting a combination of the adenosine A1 agonist 2-chloro-N6-cyclopentyladenosine (CCPA) and lidocaine as a possibly useful alternative to ischemic preconditioning in the clinical setting. As Canyon and Dobson
1
state, "A goal for more than 2 decades has been to develop a pharmacologic mimetic of IPC [ischemic preconditioning] to protect the heart during acute regional ischemia." Canyon and Dobson
1
unfortunately did not mention that volatile anesthetics are
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |